Myrotx
1 known investors
Myrobalan Therapeutics develops oral small molecule therapies targeting demyelination and neuroinflammation in central nervous system diseases such as multiple sclerosis, Alzheimer's, ALS, and Parkinson's. The company uses biomarker-guided precision neurology to identify brain-penetrant compounds for CNS drug discovery.
Investors · 1
Frequently asked questions
- What does Myrotx do?
- Myrobalan Therapeutics develops oral small molecule therapies targeting demyelination and neuroinflammation in central nervous system diseases such as multiple sclerosis, Alzheimer's, ALS, and Parkinson's. The company uses biomarker-guided precision neurology to identify brain-penetrant compounds for CNS drug discovery.
- Who are Myrotx's investors?
- Myrotx's investors include 3E Bioventures Capital.